These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16186795

  • 1. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
    Heckman CA, Duan H, Garcia PB, Boxer LM.
    Oncogene; 2006 Feb 09; 25(6):888-98. PubMed ID: 16186795
    [Abstract] [Full Text] [Related]

  • 2. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
    Heckman CA, Wheeler MA, Boxer LM.
    Oncogene; 2003 Sep 11; 22(39):7891-9. PubMed ID: 12970736
    [Abstract] [Full Text] [Related]

  • 3. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H, Heckman CA, Boxer LM.
    Oncogene; 2007 Apr 19; 26(18):2635-41. PubMed ID: 17043638
    [Abstract] [Full Text] [Related]

  • 4. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Heckman CA, Mehew JW, Boxer LM.
    Oncogene; 2002 May 30; 21(24):3898-908. PubMed ID: 12032828
    [Abstract] [Full Text] [Related]

  • 5. Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.
    Heckman CA, Cao T, Somsouk L, Duan H, Mehew JW, Zhang CY, Boxer LM.
    Cancer Res; 2003 Oct 15; 63(20):6666-73. PubMed ID: 14583460
    [Abstract] [Full Text] [Related]

  • 6. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
    Turner EC, Kinsella BT.
    J Mol Biol; 2009 Feb 27; 386(3):579-97. PubMed ID: 19118563
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif.
    Felli MP, Moschella C, Farina AR, Alesse E, Screpanti I, Teti D, Frati L, Gulino A.
    Cell Immunol; 1996 Sep 15; 172(2):229-34. PubMed ID: 8964085
    [Abstract] [Full Text] [Related]

  • 9. Glutamate-induced octamer DNA binding and transcriptional control in cultured radial glia cells.
    López-Bayghen E, Cruz-Solís I, Corona M, López-Colomé AM, Ortega A.
    J Neurochem; 2006 Aug 15; 98(3):851-9. PubMed ID: 16787415
    [Abstract] [Full Text] [Related]

  • 10. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J.
    J Pathol; 2005 Jul 15; 206(3):312-9. PubMed ID: 15892171
    [Abstract] [Full Text] [Related]

  • 11. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T.
    Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847
    [Abstract] [Full Text] [Related]

  • 12. Btk expression is controlled by Oct and BOB.1/OBF.1.
    Brunner C, Wirth T.
    Nucleic Acids Res; 2006 Oct 01; 34(6):1807-15. PubMed ID: 16582106
    [Abstract] [Full Text] [Related]

  • 13. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
    Peng S, Lalani S, Leavenworth JW, Ho IC, Pauza ME.
    Eur J Immunol; 2007 Oct 01; 37(10):2868-80. PubMed ID: 17823980
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
    Arcinas M, Heckman CA, Mehew JW, Boxer LM.
    Cancer Res; 2001 Jul 01; 61(13):5202-6. PubMed ID: 11431360
    [Abstract] [Full Text] [Related]

  • 15. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
    Re D, Müschen M, Ahmadi T, Wickenhauser C, Staratschek-Jox A, Holtick U, Diehl V, Wolf J.
    Cancer Res; 2001 Mar 01; 61(5):2080-4. PubMed ID: 11280769
    [Abstract] [Full Text] [Related]

  • 16. Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization.
    Romero F, Martínez-A C, Camonis J, Rebollo A.
    EMBO J; 1999 Jun 15; 18(12):3419-30. PubMed ID: 10369681
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
    Fiala-Beer E, Lee AC, Murray M.
    Int J Biochem Cell Biol; 2007 Jun 15; 39(6):1235-47. PubMed ID: 17481938
    [Abstract] [Full Text] [Related]

  • 18. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [Abstract] [Full Text] [Related]

  • 19. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.
    Duan H, Xiang H, Ma L, Boxer LM.
    Oncogene; 2008 Dec 04; 27(53):6720-8. PubMed ID: 18695675
    [Abstract] [Full Text] [Related]

  • 20. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis.
    Kondo E, Yoshino T.
    Pathol Int; 2007 Jul 04; 57(7):391-7. PubMed ID: 17587238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.